Mirae Asset Global Investments
AMRX icon

Mirae Asset Global Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Mirae Asset Global Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Sell
14,268
-2,143
-13% -$29.4K ﹤0.01% 1086
2026
Q1 		$204K Buy
16,411
+1,135
+7% +$15.2K ﹤0.01% 1069
2025
Q4 		$192K Buy
15,276
+3,134
+26% +$35.9K ﹤0.01% 1150
2025
Q3 		$122K Buy
12,142
+35
+0.3% +$314 ﹤0.01% 1180
2025
Q2 		$97.9K Buy
12,107
+1,735
+17% +$13.1K ﹤0.01% 1139
2025
Q1 		$85.9K Buy
10,372
+47
+0.5% +$392 ﹤0.01% 1146
2024
Q4 		$80.7K Buy
+10,325
New +$86.6K ﹤0.01% 1187

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments's AMRX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Amneal Pharmaceuticals (AMRX) stake by 13% in Q2 2026, selling an estimated $29.4K and leaving 14,268 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

Mirae Asset Global Investments first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 130 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Mirae Asset Global Investments held 14,268 shares of Amneal Pharmaceuticals worth $247K as of Q2 2026.
  • Mirae Asset Global Investments sold 2,143 Amneal Pharmaceuticals shares in Q2 2026, an estimated $29.4K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1086 holding.
  • Mirae Asset Global Investments first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 130 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.